Markets Gone Wild

Cognition Therapeutics Presents Scientific Rationale, Clinical Biomarker and Preclinical Data PURCHASE, N.Y., Dec. 01, 2022 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (Nasdaq: CGTX), (the “Company” or “Cognition”) today announced that the scientific rationale, supporting proof-of-concept data and design of the planned Phase 2 trial of CT1812 in geographic atrophy (GA) secondary to dry age-related macular…

Advantest Unveils E5620 DR-SEM for Review and Classification of Ultra-Small Photomasks Overview Advantest Corporation has introduced its latest cutting-edge technology, the E5620 Defect Review Scanning Electron Microscope (DR-SEM). This innovative mask SEM product is designed to review and classify ultra-small defects on photomasks and mask blanks with high precision and efficiency. Features The E5620 DR-SEM…

Once again, our leader, Mr. Sudip Saha, MD and Co-founder, has been felicitated and recognized by The Economic Times and The Times Of India, as the ‘Global Icon in Business Consulting’ at the recently concluded Inspiring Leaders Award Nov 2022 in recognition of his immense impact in the industry of Market Research & Consulting Mr….

Market Update: Asia Pacific Stocks Surge Overview Asia Pacific stocks rallied on the heels of the surge in US equities. China’s CSI 300 led the large bourses higher with a 1% advance. Europe’s Stoxx 600 is matching yesterday’s gain of a little more than 0.6%, while US futures are a touch softer. European yields are…

Am I at Risk of Being Investigated by Bragar Eagel & Squire, P.C.? It’s Not You, It’s KnowBe4, Inc. So, picture this: you wake up one morning, reach for your phone, and immediately get bombarded with alarming news about a company called KnowBe4, Inc. being investigated by Bragar Eagel & Squire, P.C. Your first thought?…

RAPT Therapeutics to Present FLX475 Phase 1/2 Data at the European Society for Medical Oncology Immuno-Oncology Congress Exciting News from RAPT Therapeutics SOUTH SAN FRANCISCO, Calif., Nov. 30, 2022 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT” or the “Company”), a clinical-stage, immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule…

Edge Total Intelligence Inc. Reports Third Quarter 2022 Results and Provides Operational Overview ARLINGTON, Va., Nov. 30, 2022 (GLOBE NEWSWIRE) — Edge Total Intelligence Inc. Financial Highlights Edge Total Intelligence Inc. (TSXV: CTRL, OTC: UNFYF, FSE: Q5i) announced its operating and consolidated results for the third quarter of 2022. The financial information is expressed in…

UnitedHealthcare Owes $10 Million for Underpaying Frontline Clinicians – TeamHealth Wins Legal Battle The Backstory UnitedHealthcare (United) has once again found themselves in hot water for putting profits over the well-being of patients and healthcare providers. In a recent legal battle, United was found guilty of intentionally and systematically underpaying TeamHealth clinicians. This unethical practice…